25 XP   0   0   10

Shanghai Runda Med Tech Co
Buy, Hold or Sell?

Let's analyse Shanghai Runda Med Tech Co together

PenkeI guess you are interested in Shanghai Runda Med Tech Co. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Shanghai Runda Med Tech Co. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Shanghai Runda Med Tech Co

I send you an email if I find something interesting about Shanghai Runda Med Tech Co.

Quick analysis of Shanghai Runda Med Tech Co (30 sec.)










What can you expect buying and holding a share of Shanghai Runda Med Tech Co? (30 sec.)

How much money do you get?

How much money do you get?
¥0.09
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
¥8.81
Expected worth in 1 year
¥9.46
How sure are you?
100.0%

+ What do you gain per year?

Total Gains per Share
¥1.28
Return On Investment
6.2%

For what price can you sell your share?

Current Price per Share
¥20.61
Expected price per share
¥12.11 - ¥27.70
How sure are you?
50%

1. Valuation of Shanghai Runda Med Tech Co (5 min.)




Live pricePrice per Share (EOD)

¥20.61

Intrinsic Value Per Share

¥3.87 - ¥4.82

Total Value Per Share

¥12.68 - ¥13.63

2. Growth of Shanghai Runda Med Tech Co (5 min.)




Is Shanghai Runda Med Tech Co growing?

Current yearPrevious yearGrowGrow %
How rich?$728.1m$635.3m$74.4m10.5%

How much money is Shanghai Runda Med Tech Co making?

Current yearPrevious yearGrowGrow %
Making money$13.6m$12.4m$1.1m8.7%
Net Profit Margin4.1%3.5%--

How much money comes from the company's main activities?

3. Financial Health of Shanghai Runda Med Tech Co (5 min.)




4. Comparing to competitors in the Diagnostics & Research industry (5 min.)




  Industry Rankings (Diagnostics & Research)  


Richest
#38 / 148

Most Revenue
#29 / 148

Most Profit
#38 / 148

What can you expect buying and holding a share of Shanghai Runda Med Tech Co? (5 min.)

Welcome investor! Shanghai Runda Med Tech Co's management wants to use your money to grow the business. In return you get a share of Shanghai Runda Med Tech Co.

What can you expect buying and holding a share of Shanghai Runda Med Tech Co?

First you should know what it really means to hold a share of Shanghai Runda Med Tech Co. And how you can make/lose money.

Speculation

The Price per Share of Shanghai Runda Med Tech Co is ¥20.61. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Shanghai Runda Med Tech Co.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Shanghai Runda Med Tech Co, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ¥8.81. Based on the TTM, the Book Value Change Per Share is ¥0.16 per quarter. Based on the YOY, the Book Value Change Per Share is ¥0.22 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ¥0.16 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Shanghai Runda Med Tech Co.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share
Usd Eps0.030.1%0.020.1%0.020.1%0.020.1%0.020.1%
Usd Book Value Change Per Share0.030.1%0.020.1%0.030.1%0.030.1%0.030.2%
Usd Dividend Per Share0.040.2%0.020.1%0.010.1%0.020.1%0.010.1%
Usd Total Gains Per Share0.070.3%0.040.2%0.040.2%0.040.2%0.050.2%
Usd Price Per Share2.06-2.05-1.59-1.63-2.88-
Price to Earnings Ratio20.46-23.13-25.94-27.24-94.27-
Price-to-Total Gains Ratio30.83-53.64-46.58-46.00-156.25-
Price to Book Ratio1.69-1.72-1.50-1.69-8.66-
Price-to-Total Gains Ratio30.83-53.64-46.58-46.00-156.25-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share2.852424
Number of shares350
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.020.02
Usd Book Value Change Per Share0.020.03
Usd Total Gains Per Share0.040.04
Gains per Quarter (350 shares)15.4414.52
Gains per Year (350 shares)61.7858.07
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1303152223648
261631144571106
3919417667107164
412112623890143222
5152157300112178280
6182189362134214338
7212220424157250396
8242252486179286454
9273283548201321512
10303315610224357570

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%37.00.00.0100.0%37.00.00.0100.0%
Book Value Change Per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%36.00.01.097.3%36.00.01.097.3%
Dividend per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%37.00.00.0100.0%37.00.00.0100.0%
Total Gains per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%37.00.00.0100.0%37.00.00.0100.0%

Fundamentals of Shanghai Runda Med Tech Co

About Shanghai Runda Med Tech Co

Shanghai Runda Medical Technology Co., Ltd. provides integrated medical laboratory services in China. It offers platform supply, laboratory design/renovation, laboratory standardization, and information management system services; medical solutions to help healthcare professionals in the areas of biochemistry, diabetes, POCT, immunoassay analyzer, and molecular biology diagnosis; professional technical services; and logistic services. The company was founded in 1999 and is based in Shanghai, China.

Fundamental data was last updated by Penke on 2024-03-27 21:15:09.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is inefficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is just not able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is fair priced.
Based on how much money comes from the company's main activities, the company is cheap.

1.1. Profitability of Shanghai Runda Med Tech Co.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Shanghai Runda Med Tech Co earns for each ¥1 of revenue.

  • Above 10% is considered healthy but always compare Shanghai Runda Med Tech Co to the Diagnostics & Research industry mean.
  • A Net Profit Margin of 4.6% means that ¥0.05 for each ¥1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Shanghai Runda Med Tech Co:

  • The MRQ is 4.6%. The company is making a profit. +1
  • The TTM is 4.1%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ4.6%TTM4.1%+0.5%
TTM4.1%YOY3.5%+0.5%
TTM4.1%5Y4.1%0.0%
5Y4.1%10Y4.7%-0.6%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ4.6%-5.2%+9.8%
TTM4.1%-6.0%+10.1%
YOY3.5%-1.8%+5.3%
5Y4.1%-8.0%+12.1%
10Y4.7%-4.4%+9.1%
1.1.2. Return on Assets

Shows how efficient Shanghai Runda Med Tech Co is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Shanghai Runda Med Tech Co to the Diagnostics & Research industry mean.
  • 0.7% Return on Assets means that Shanghai Runda Med Tech Co generated ¥0.01 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Shanghai Runda Med Tech Co:

  • The MRQ is 0.7%. Using its assets, the company is inefficient in making profit. -1
  • The TTM is 0.7%. Using its assets, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ0.7%TTM0.7%+0.1%
TTM0.7%YOY0.7%0.0%
TTM0.7%5Y0.8%-0.1%
5Y0.8%10Y1.0%-0.2%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7%-0.9%+1.6%
TTM0.7%-0.8%+1.5%
YOY0.7%-1.3%+2.0%
5Y0.8%-1.2%+2.0%
10Y1.0%-0.8%+1.8%
1.1.3. Return on Equity

Shows how efficient Shanghai Runda Med Tech Co is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Shanghai Runda Med Tech Co to the Diagnostics & Research industry mean.
  • 2.7% Return on Equity means Shanghai Runda Med Tech Co generated ¥0.03 for each ¥1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Shanghai Runda Med Tech Co:

  • The MRQ is 2.7%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 2.5%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ2.7%TTM2.5%+0.2%
TTM2.5%YOY2.5%+0.0%
TTM2.5%5Y2.6%-0.1%
5Y2.6%10Y2.8%-0.1%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ2.7%-0.4%+3.1%
TTM2.5%-0.3%+2.8%
YOY2.5%-1.0%+3.5%
5Y2.6%-1.7%+4.3%
10Y2.8%-2.1%+4.9%

1.2. Operating Efficiency of Shanghai Runda Med Tech Co.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Shanghai Runda Med Tech Co is operating .

  • Measures how much profit Shanghai Runda Med Tech Co makes for each ¥1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Shanghai Runda Med Tech Co to the Diagnostics & Research industry mean.
  • An Operating Margin of 0.0% means the company generated ¥0.00  for each ¥1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Shanghai Runda Med Tech Co:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM6.8%-6.8%
TTM6.8%YOY9.8%-3.0%
TTM6.8%5Y10.1%-3.3%
5Y10.1%10Y5.8%+4.2%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ--9.4%+9.4%
TTM6.8%-0.1%+6.9%
YOY9.8%3.3%+6.5%
5Y10.1%0.3%+9.8%
10Y5.8%-2.7%+8.5%
1.2.2. Operating Ratio

Measures how efficient Shanghai Runda Med Tech Co is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Diagnostics & Research industry mean).
  • An Operation Ratio of 1.69 means that the operating costs are ¥1.69 for each ¥1 in net sales.

Let's take a look of the Operating Ratio trends of Shanghai Runda Med Tech Co:

  • The MRQ is 1.692. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.615. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.692TTM1.615+0.077
TTM1.615YOY1.622-0.007
TTM1.6155Y1.615+0.000
5Y1.61510Y1.217+0.397
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ1.6921.315+0.377
TTM1.6151.297+0.318
YOY1.6221.277+0.345
5Y1.6151.246+0.369
10Y1.2171.215+0.002

1.3. Liquidity of Shanghai Runda Med Tech Co.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Shanghai Runda Med Tech Co is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Diagnostics & Research industry mean).
  • A Current Ratio of 1.28 means the company has ¥1.28 in assets for each ¥1 in short-term debts.

Let's take a look of the Current Ratio trends of Shanghai Runda Med Tech Co:

  • The MRQ is 1.285. The company is just able to pay all its short-term debts.
  • The TTM is 1.206. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.285TTM1.206+0.078
TTM1.206YOY1.198+0.008
TTM1.2065Y1.168+0.038
5Y1.16810Y0.663+0.505
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ1.2852.183-0.898
TTM1.2062.341-1.135
YOY1.1982.625-1.427
5Y1.1682.989-1.821
10Y0.6632.958-2.295
1.3.2. Quick Ratio

Measures if Shanghai Runda Med Tech Co is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Shanghai Runda Med Tech Co to the Diagnostics & Research industry mean.
  • A Quick Ratio of 0.78 means the company can pay off ¥0.78 for each ¥1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Shanghai Runda Med Tech Co:

  • The MRQ is 0.785. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.767. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.785TTM0.767+0.018
TTM0.767YOY0.757+0.010
TTM0.7675Y0.708+0.059
5Y0.70810Y0.674+0.034
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7851.310-0.525
TTM0.7671.437-0.670
YOY0.7571.764-1.007
5Y0.7081.952-1.244
10Y0.6742.080-1.406

1.4. Solvency of Shanghai Runda Med Tech Co.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Shanghai Runda Med Tech Co assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Shanghai Runda Med Tech Co to Diagnostics & Research industry mean.
  • A Debt to Asset Ratio of 0.64 means that Shanghai Runda Med Tech Co assets are financed with 63.9% credit (debt) and the remaining percentage (100% - 63.9%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Shanghai Runda Med Tech Co:

  • The MRQ is 0.639. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.650. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.639TTM0.650-0.011
TTM0.650YOY0.646+0.004
TTM0.6505Y0.623+0.027
5Y0.62310Y0.569+0.053
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6390.432+0.207
TTM0.6500.431+0.219
YOY0.6460.377+0.269
5Y0.6230.443+0.180
10Y0.5690.446+0.123
1.4.2. Debt to Equity Ratio

Measures if Shanghai Runda Med Tech Co is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Shanghai Runda Med Tech Co to the Diagnostics & Research industry mean.
  • A Debt to Equity ratio of 227.9% means that company has ¥2.28 debt for each ¥1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Shanghai Runda Med Tech Co:

  • The MRQ is 2.279. The company is just not able to pay all its debts with equity.
  • The TTM is 2.394. The company is just not able to pay all its debts with equity.
Trends
Current periodCompared to+/- 
MRQ2.279TTM2.394-0.114
TTM2.394YOY2.339+0.054
TTM2.3945Y2.122+0.272
5Y2.12210Y1.725+0.397
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ2.2790.606+1.673
TTM2.3940.595+1.799
YOY2.3390.603+1.736
5Y2.1220.636+1.486
10Y1.7250.730+0.995

2. Market Valuation of Shanghai Runda Med Tech Co

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ¥1 in earnings Shanghai Runda Med Tech Co generates.

  • Above 15 is considered overpriced but always compare Shanghai Runda Med Tech Co to the Diagnostics & Research industry mean.
  • A PE ratio of 20.46 means the investor is paying ¥20.46 for every ¥1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Shanghai Runda Med Tech Co:

  • The EOD is 28.371. Based on the earnings, the company is overpriced. -1
  • The MRQ is 20.456. Based on the earnings, the company is fair priced.
  • The TTM is 23.127. Based on the earnings, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD28.371MRQ20.456+7.915
MRQ20.456TTM23.127-2.671
TTM23.127YOY25.941-2.815
TTM23.1275Y27.236-4.110
5Y27.23610Y94.266-67.030
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD28.371-0.300+28.671
MRQ20.456-0.567+21.023
TTM23.127-0.341+23.468
YOY25.941-0.242+26.183
5Y27.236-0.129+27.365
10Y94.2663.396+90.870
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Shanghai Runda Med Tech Co:

  • The EOD is 28.635. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The MRQ is 20.646. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The TTM is 13.086. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD28.635MRQ20.646+7.989
MRQ20.646TTM13.086+7.561
TTM13.086YOY-30.700+43.786
TTM13.0865Y-11.901+24.987
5Y-11.90110Y-15.868+3.967
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD28.635-0.460+29.095
MRQ20.646-0.918+21.564
TTM13.086-1.763+14.849
YOY-30.700-3.236-27.464
5Y-11.901-2.150-9.751
10Y-15.868-3.427-12.441
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Shanghai Runda Med Tech Co is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Diagnostics & Research industry mean).
  • A PB ratio of 1.69 means the investor is paying ¥1.69 for each ¥1 in book value.

Let's take a look of the Price to Book Ratio trends of Shanghai Runda Med Tech Co:

  • The EOD is 2.340. Based on the equity, the company is underpriced. +1
  • The MRQ is 1.687. Based on the equity, the company is underpriced. +1
  • The TTM is 1.723. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD2.340MRQ1.687+0.653
MRQ1.687TTM1.723-0.036
TTM1.723YOY1.500+0.224
TTM1.7235Y1.691+0.033
5Y1.69110Y8.660-6.970
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD2.3402.021+0.319
MRQ1.6872.140-0.453
TTM1.7232.126-0.403
YOY1.5003.071-1.571
5Y1.6913.399-1.708
10Y8.6604.152+4.508
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Shanghai Runda Med Tech Co compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.1930.162+19%0.221-13%0.184+5%0.238-19%
Book Value Per Share--8.8088.587+3%7.686+15%7.025+25%5.053+74%
Current Ratio--1.2851.206+6%1.198+7%1.168+10%0.663+94%
Debt To Asset Ratio--0.6390.650-2%0.646-1%0.623+3%0.569+12%
Debt To Equity Ratio--2.2792.394-5%2.339-3%2.122+7%1.725+32%
Dividend Per Share--0.2890.156+85%0.102+184%0.115+150%0.098+195%
Eps--0.1820.165+10%0.151+20%0.146+25%0.111+64%
Free Cash Flow Per Share--0.1800.080+125%-0.233+230%-0.040+122%-0.036+120%
Free Cash Flow To Equity Per Share--0.1800.067+168%-0.027+115%0.080+124%0.056+223%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--4.818--------
Intrinsic Value_10Y_min--3.872--------
Intrinsic Value_1Y_max---0.227--------
Intrinsic Value_1Y_min---0.224--------
Intrinsic Value_3Y_max---0.142--------
Intrinsic Value_3Y_min---0.147--------
Intrinsic Value_5Y_max--0.596--------
Intrinsic Value_5Y_min--0.507--------
Market Cap12310064789.760+28%8875670197.7608853271972.160+0%6843404528.320+30%7048870917.824+26%12433076651.899-29%
Net Profit Margin--0.0460.041+13%0.035+29%0.041+12%0.047-2%
Operating Margin---0.068-100%0.098-100%0.101-100%0.058-100%
Operating Ratio--1.6921.615+5%1.622+4%1.615+5%1.217+39%
Pb Ratio2.340+28%1.6871.723-2%1.500+13%1.6910%8.660-81%
Pe Ratio28.371+28%20.45623.127-12%25.941-21%27.236-25%94.266-78%
Price Per Share20.610+28%14.86014.823+0%11.458+30%11.802+26%20.816-29%
Price To Free Cash Flow Ratio28.635+28%20.64613.086+58%-30.700+249%-11.901+158%-15.868+177%
Price To Total Gains Ratio42.766+28%30.83553.637-43%46.580-34%45.998-33%156.253-80%
Quick Ratio--0.7850.767+2%0.757+4%0.708+11%0.674+16%
Return On Assets--0.0070.007+10%0.007+10%0.008-4%0.010-23%
Return On Equity--0.0270.025+7%0.025+7%0.026+1%0.028-4%
Total Gains Per Share--0.4820.319+51%0.323+49%0.300+61%0.336+43%
Usd Book Value--728132971.869709807459.570+3%635348569.725+15%580681438.440+25%417669133.099+74%
Usd Book Value Change Per Share--0.0270.022+19%0.031-13%0.025+5%0.033-19%
Usd Book Value Per Share--1.2191.188+3%1.064+15%0.972+25%0.699+74%
Usd Dividend Per Share--0.0400.022+85%0.014+184%0.016+150%0.014+195%
Usd Eps--0.0250.023+10%0.021+20%0.020+25%0.015+64%
Usd Free Cash Flow--14874414.3656610597.983+125%-19291642.714+230%-3292182.073+122%-1860573.317+113%
Usd Free Cash Flow Per Share--0.0250.011+125%-0.032+230%-0.006+122%-0.005+120%
Usd Free Cash Flow To Equity Per Share--0.0250.009+168%-0.004+115%0.011+124%0.008+223%
Usd Market Cap1703712966.903+28%1228392755.3701225292840.947+0%947127186.719+30%975563735.027+26%1720737808.623-29%
Usd Price Per Share2.852+28%2.0572.051+0%1.586+30%1.633+26%2.881-29%
Usd Profit--15012849.75413672406.575+10%12482367.115+20%12038453.061+25%9157048.371+64%
Usd Revenue--327870501.560337372377.636-3%336350877.619-3%290598235.858+13%206085560.388+59%
Usd Total Gains Per Share--0.0670.044+51%0.045+49%0.041+61%0.047+43%
 EOD+4 -4MRQTTM+29 -6YOY+26 -95Y+27 -810Y+21 -14

3.2. Fundamental Score

Let's check the fundamental score of Shanghai Runda Med Tech Co based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1528.371
Price to Book Ratio (EOD)Between0-12.340
Net Profit Margin (MRQ)Greater than00.046
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.785
Current Ratio (MRQ)Greater than11.285
Debt to Asset Ratio (MRQ)Less than10.639
Debt to Equity Ratio (MRQ)Less than12.279
Return on Equity (MRQ)Greater than0.150.027
Return on Assets (MRQ)Greater than0.050.007
Total3/10 (30.0%)

3.3. Technical Score

Let's check the technical score of Shanghai Runda Med Tech Co based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5050.627
Ma 20Greater thanMa 5021.198
Ma 50Greater thanMa 10018.536
Ma 100Greater thanMa 20020.321
OpenGreater thanClose20.100
Total3/5 (60.0%)



Latest Balance Sheet

Balance Sheet of 2023-09-30. Currency in CNY. All numbers in thousands.

Summary
Total Assets14,564,671
Total Liabilities9,303,594
Total Stockholder Equity4,082,056
 As reported
Total Liabilities 9,303,594
Total Stockholder Equity+ 4,082,056
Total Assets = 14,564,671

Assets

Total Assets14,564,671
Total Current Assets9,859,465
Long-term Assets4,705,206
Total Current Assets
Cash And Cash Equivalents 916,707
Short-term Investments 110,000
Net Receivables 5,912,417
Inventory 1,524,290
Other Current Assets 59,539
Total Current Assets  (as reported)9,859,465
Total Current Assets  (calculated)8,522,953
+/- 1,336,512
Long-term Assets
Property Plant Equipment 1,135,315
Goodwill 1,986,549
Intangible Assets 64,931
Long-term Assets Other 11,426
Long-term Assets  (as reported)4,705,206
Long-term Assets  (calculated)3,198,222
+/- 1,506,984

Liabilities & Shareholders' Equity

Total Current Liabilities7,675,455
Long-term Liabilities1,628,140
Total Stockholder Equity4,082,056
Total Current Liabilities
Short Long Term Debt 4,921,510
Accounts payable 1,658,667
Other Current Liabilities 30,113
Total Current Liabilities  (as reported)7,675,455
Total Current Liabilities  (calculated)6,610,290
+/- 1,065,164
Long-term Liabilities
Long term Debt 1,425,127
Capital Lease Obligations Min Short Term Debt105,735
Long-term Liabilities Other 9,997
Long-term Liabilities  (as reported)1,628,140
Long-term Liabilities  (calculated)1,540,860
+/- 87,280
Total Stockholder Equity
Retained Earnings 2,366,390
Total Stockholder Equity (as reported)4,082,056
Total Stockholder Equity (calculated)2,366,390
+/- 1,715,666
Other
Capital Stock579,642
Common Stock Shares Outstanding 579,642
Net Debt 5,429,930
Net Invested Capital 10,428,693
Net Working Capital 2,184,010
Property Plant and Equipment Gross 1,135,315



Balance Sheet

Currency in CNY. All numbers in thousands.

 Trend2023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-03-31
> Total Assets 
0
1,084,895
1,158,615
1,593,620
1,563,457
1,693,816
1,896,930
2,198,534
2,650,502
4,107,955
4,531,354
4,671,600
6,531,807
7,125,329
7,518,246
7,645,297
7,454,377
7,542,988
8,021,206
8,169,166
8,588,929
9,032,849
8,982,359
9,906,001
9,821,907
10,176,547
10,993,794
11,520,818
12,111,791
12,016,544
12,495,027
13,385,081
14,084,217
14,518,862
14,673,621
14,829,653
14,564,671
14,564,67114,829,65314,673,62114,518,86214,084,21713,385,08112,495,02712,016,54412,111,79111,520,81810,993,79410,176,5479,821,9079,906,0018,982,3599,032,8498,588,9298,169,1668,021,2067,542,9887,454,3777,645,2977,518,2467,125,3296,531,8074,671,6004,531,3544,107,9552,650,5022,198,5341,896,9301,693,8161,563,4571,593,6201,158,6151,084,8950
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4,238,536
4,284,265
4,788,267
4,911,557
5,295,219
5,636,921
5,595,158
6,443,671
6,006,586
6,227,322
6,577,042
7,126,065
7,580,671
7,442,200
7,903,547
8,757,392
9,401,501
9,819,158
9,958,089
10,089,639
9,859,465
9,859,46510,089,6399,958,0899,819,1589,401,5018,757,3927,903,5477,442,2007,580,6717,126,0656,577,0426,227,3226,006,5866,443,6715,595,1585,636,9215,295,2194,911,5574,788,2674,284,2654,238,5360000000000000000
       Cash And Cash Equivalents 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
366,158
372,655
645,947
696,329
607,002
844,247
788,001
1,429,494
765,017
834,880
541,786
832,272
843,113
1,023,536
887,947
933,567
929,041
1,007,052
1,082,919
1,131,738
916,707
916,7071,131,7381,082,9191,007,052929,041933,567887,9471,023,536843,113832,272541,786834,880765,0171,429,494788,001844,247607,002696,329645,947372,655366,1580000000000000000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
120,000
12,000
282,600
226,300
169,600
96,640
37,990
67,300
25,490
17,000
178,000
83,700
106,500
125,000
129,900
110,000
110,000129,900125,000106,50083,700178,00017,00025,49067,30037,99096,640169,600226,300282,60012,000120,000000000000000000000000
       Net Receivables 
0
385,370
424,740
455,918
501,228
580,834
642,560
716,641
894,820
1,011,998
1,274,493
1,379,168
1,771,701
1,971,387
2,204,735
2,439,954
2,520,348
2,516,163
2,601,247
2,680,970
2,919,934
3,232,853
3,110,009
3,196,030
3,418,870
3,649,296
4,229,143
4,427,803
4,629,691
4,513,150
4,903,962
5,447,723
6,038,391
6,270,233
6,234,036
6,395,995
5,912,417
5,912,4176,395,9956,234,0366,270,2336,038,3915,447,7234,903,9624,513,1504,629,6914,427,8034,229,1433,649,2963,418,8703,196,0303,110,0093,232,8532,919,9342,680,9702,601,2472,516,1632,520,3482,439,9542,204,7351,971,3871,771,7011,379,1681,274,4931,011,998894,820716,641642,560580,834501,228455,918424,740385,3700
       Other Current Assets 
0
35,940
41,470
73,581
87,522
41,489
99,784
125,276
143,337
115,554
219,159
172,371
252,261
162,963
343,761
234,507
271,509
247,244
127,791
35,353
48,383
262,578
442,598
321,284
305,986
419,830
439,155
467,655
572,546
377,587
572,913
642,361
705,432
819,439
990,765
1,014,233
59,539
59,5391,014,233990,765819,439705,432642,361572,913377,587572,546467,655439,155419,830305,986321,284442,598262,57848,38335,353127,791247,244271,509234,507343,761162,963252,261172,371219,159115,554143,337125,27699,78441,48987,52273,58141,47035,9400
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,232,938
3,257,610
3,293,710
3,395,928
3,387,202
3,462,329
3,815,322
3,949,226
4,416,752
4,394,753
4,531,120
4,574,344
4,591,479
4,627,689
4,682,715
4,699,705
4,715,532
4,740,013
4,705,206
4,705,2064,740,0134,715,5324,699,7054,682,7154,627,6894,591,4794,574,3444,531,1204,394,7534,416,7523,949,2263,815,3223,462,3293,387,2023,395,9283,293,7103,257,6103,232,938000000000000000000
       Property Plant Equipment 
0
237,725
251,747
301,127
310,134
368,743
405,525
440,423
490,790
585,612
641,779
688,896
761,852
768,783
771,701
778,724
814,196
869,248
848,537
840,955
846,256
888,470
848,525
847,173
873,264
932,240
1,182,000
1,157,316
1,166,601
1,186,546
1,177,650
1,172,078
1,181,778
1,156,806
1,131,596
1,152,756
1,135,315
1,135,3151,152,7561,131,5961,156,8061,181,7781,172,0781,177,6501,186,5461,166,6011,157,3161,182,000932,240873,264847,173848,525888,470846,256840,955848,537869,248814,196778,724771,701768,783761,852688,896641,779585,612490,790440,423405,525368,743310,134301,127251,747237,7250
       Goodwill 
0
1,435
1,435
2,066
2,066
2,527
2,527
2,527
90,280
481,244
658,985
658,985
1,598,268
1,669,833
1,669,833
1,669,833
1,669,833
1,655,753
1,655,753
1,655,753
1,738,509
1,714,084
1,714,087
1,714,084
1,793,899
1,793,900
2,016,869
2,016,869
2,016,869
1,897,656
1,897,656
1,897,656
1,897,656
1,987,641
1,987,641
1,987,641
1,986,549
1,986,5491,987,6411,987,6411,987,6411,897,6561,897,6561,897,6561,897,6562,016,8692,016,8692,016,8691,793,9001,793,8991,714,0841,714,0871,714,0841,738,5091,655,7531,655,7531,655,7531,669,8331,669,8331,669,8331,669,8331,598,268658,985658,985481,24490,2802,5272,5272,5272,0662,0661,4351,4350
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
517,318
497,330
512,903
541,828
467,104
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000467,104541,828512,903497,330517,3180000000000000000
       Intangible Assets 
0
26,537
25,884
26,337
26,675
31,125
30,136
29,438
116,296
517,937
694,451
693,147
1,631,133
1,702,778
1,702,783
1,701,250
32,384
31,601
30,601
15,977
51,484
56,980
55,956
59,135
58,500
60,726
59,067
56,352
57,414
67,710
67,036
63,423
69,414
69,459
75,403
74,197
64,931
64,93174,19775,40369,45969,41463,42367,03667,71057,41456,35259,06760,72658,50059,13555,95656,98051,48415,97730,60131,60132,3841,701,2501,702,7831,702,7781,631,133693,147694,451517,937116,29629,43830,13631,12526,67526,33725,88426,5370
       Other Assets 
0
48,159
48,582
51,793
75,278
117,407
115,338
125,999
286,712
800,686
1,166,460
1,208,663
2,212,003
2,517,177
2,544,641
2,366,727
182,111
204,792
185,145
189,210
190,357
222,312
221,465
226,693
237,077
267,126
279,051
278,119
295,117
292,204
302,584
322,444
336,847
356,888
361,571
361,261
0
0361,261361,571356,888336,847322,444302,584292,204295,117278,119279,051267,126237,077226,693221,465222,312190,357189,210185,145204,792182,1112,366,7272,544,6412,517,1772,212,0031,208,6631,166,460800,686286,712125,999115,338117,40775,27851,79348,58248,1590
> Total Liabilities 
0
609,269
673,429
725,341
668,198
765,265
949,197
1,229,831
1,607,200
1,885,795
2,173,864
2,282,278
3,919,256
4,376,774
4,694,012
4,726,127
4,393,900
4,412,146
4,730,025
4,802,159
5,089,752
5,516,456
5,429,421
6,120,611
5,889,124
6,096,311
6,758,250
7,222,079
7,765,858
7,624,504
8,042,302
8,740,262
9,211,125
9,509,012
9,575,695
9,683,839
9,303,594
9,303,5949,683,8399,575,6959,509,0129,211,1258,740,2628,042,3027,624,5047,765,8587,222,0796,758,2506,096,3115,889,1246,120,6115,429,4215,516,4565,089,7524,802,1594,730,0254,412,1464,393,9004,726,1274,694,0124,376,7743,919,2562,282,2782,173,8641,885,7951,607,2001,229,831949,197765,265668,198725,341673,429609,2690
   > Total Current Liabilities 
0
555,643
627,969
670,045
622,374
721,764
878,638
1,164,937
1,550,233
1,652,645
1,949,856
1,998,967
2,915,095
3,191,516
3,489,511
3,507,670
3,630,502
3,594,829
4,022,116
4,102,745
4,479,507
5,214,141
5,161,109
5,468,291
5,362,252
5,543,585
5,921,516
6,380,738
6,492,622
6,182,126
6,617,229
7,402,417
7,761,396
8,508,790
8,526,958
8,281,382
7,675,455
7,675,4558,281,3828,526,9588,508,7907,761,3967,402,4176,617,2296,182,1266,492,6226,380,7385,921,5165,543,5855,362,2525,468,2915,161,1095,214,1414,479,5074,102,7454,022,1163,594,8293,630,5023,507,6703,489,5113,191,5162,915,0951,998,9671,949,8561,652,6451,550,2331,164,937878,638721,764622,374670,045627,969555,6430
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
81,186
1,849,871
1,872,659
1,875,688
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000001,875,6881,872,6591,849,87181,18600000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
81,186
1,849,871
1,872,659
1,875,688
2,317,405
2,978,421
3,589,951
3,548,231
3,758,172
3,829,554
4,186,688
4,540,218
4,203,479
4,524,809
4,842,154
5,249,870
5,214,906
5,447,687
5,271,168
4,921,510
4,921,5105,271,1685,447,6875,214,9065,249,8704,842,1544,524,8094,203,4794,540,2184,186,6883,829,5543,758,1723,548,2313,589,9512,978,4212,317,4051,875,6881,872,6591,849,87181,18600000000000000000
       Accounts payable 
0
176,633
204,058
207,765
137,642
85,142
152,442
176,764
198,002
210,652
266,340
272,675
440,701
355,722
504,631
658,472
678,001
793,882
841,333
867,886
1,014,594
1,056,094
729,734
773,232
872,206
943,511
974,300
1,047,032
1,167,280
1,163,477
1,226,164
1,707,144
1,667,628
1,836,204
1,608,869
1,573,872
1,658,667
1,658,6671,573,8721,608,8691,836,2041,667,6281,707,1441,226,1641,163,4771,167,2801,047,032974,300943,511872,206773,232729,7341,056,0941,014,594867,886841,333793,882678,001658,472504,631355,722440,701272,675266,340210,652198,002176,764152,44285,142137,642207,765204,058176,6330
       Other Current Liabilities 
0
99,010
87,911
86,457
91,666
93,205
124,121
94,475
253,534
273,497
498,748
315,762
863,200
1,000,689
1,175,372
990,132
1,358,928
840,534
368,061
383,989
415,833
1,010,162
877,420
542,158
397,441
430,241
734,995
757,614
593,927
558,319
809,111
421,882
490,194
565,040
566,532
628,411
30,113
30,113628,411566,532565,040490,194421,882809,111558,319593,927757,614734,995430,241397,441542,158877,4201,010,162415,833383,989368,061840,5341,358,928990,1321,175,3721,000,689863,200315,762498,748273,497253,53494,475124,12193,20591,66686,45787,91199,0100
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
707,909
699,414
610,246
302,315
268,313
652,321
526,872
552,727
836,734
841,342
1,273,236
1,442,378
1,425,073
1,337,845
1,449,729
1,000,222
1,048,738
1,402,456
1,628,140
1,628,1401,402,4561,048,7381,000,2221,449,7291,337,8451,425,0731,442,3781,273,236841,342836,734552,727526,872652,321268,313302,315610,246699,414707,909000000000000000000
       Other Liabilities 
0
53,627
45,460
11,378
7,123
6,791
8,031
9,425
9,449
91,026
112,402
91,226
96,897
71,833
91,832
72,047
194,254
20,464
10,479
10,296
13,586
42,557
36,384
25,504
34,041
45,149
51,656
49,021
50,431
44,614
44,862
60,712
51,429
43,196
131,063
60,503
0
060,503131,06343,19651,42960,71244,86244,61450,43149,02151,65645,14934,04125,50436,38442,55713,58610,29610,47920,464194,25472,04791,83271,83396,89791,226112,40291,0269,4499,4258,0316,7917,12311,37845,46053,6270
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
91,084
93,006
93,820
90,855
93,567
102,431
99,752
100,409
108,934
113,848
111,528
114,897
113,905
117,087
112,931
107,489
114,201
118,141
116,435
114,043
0
0114,043116,435118,141114,201107,489112,931117,087113,905114,897111,528113,848108,934100,40999,752102,43193,56790,85593,82093,00691,0840000000000000000
> Total Stockholder Equity
404,257
475,435
484,187
867,639
893,731
924,020
939,808
953,784
989,975
2,117,256
2,150,455
2,161,880
2,237,133
2,287,045
2,343,793
2,387,552
2,486,087
2,505,563
2,624,823
2,675,561
2,742,558
2,758,404
2,791,395
2,981,902
3,107,330
3,203,388
3,295,019
3,344,282
3,404,780
3,462,734
3,503,872
3,620,021
3,766,739
3,888,414
3,970,090
3,972,743
4,082,056
4,082,0563,972,7433,970,0903,888,4143,766,7393,620,0213,503,8723,462,7343,404,7803,344,2823,295,0193,203,3883,107,3302,981,9022,791,3952,758,4042,742,5582,675,5612,624,8232,505,5632,486,0872,387,5522,343,7932,287,0452,237,1332,161,8802,150,4552,117,256989,975953,784939,808924,020893,731867,639484,187475,435404,257
   Common Stock
0
70,526
70,526
94,126
94,126
94,126
94,126
282,379
282,379
321,963
321,963
579,534
579,534
579,534
579,534
579,534
579,534
579,534
579,534
579,534
579,534
579,534
579,534
579,534
579,534
579,536
579,537
579,538
579,538
579,538
579,539
579,543
579,543
579,543
579,545
579,632
0
0579,632579,545579,543579,543579,543579,539579,538579,538579,538579,537579,536579,534579,534579,534579,534579,534579,534579,534579,534579,534579,534579,534579,534579,534579,534321,963321,963282,379282,37994,12694,12694,12694,12670,52670,5260
   Retained Earnings Total Equity0000000000000000000000000000000000000
   Accumulated Other Comprehensive Income 0000000000000000000000000000000000000
   Capital Surplus 0000000000000000000000000000000000000
   Treasury Stock0000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-199
149
225
-181
-449
-483
698
110,326
110,906
112,531
112,047
111,545
112,207
114,510
113,986
113,329
113,440
117,679
118,222
113,808
0
0113,808118,222117,679113,440113,329113,986114,510112,207111,545112,047112,531110,906110,326698-483-449-181225149-1990000000000000000



Balance Sheet

Currency in CNY. All numbers in thousands.




Cash Flow

Currency in CNY. All numbers in thousands.




Income Statement

Currency in CNY. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue9,750,647
Cost of Revenue-7,029,184
Gross Profit2,721,4622,721,462
 
Operating Income (+$)
Gross Profit2,721,462
Operating Expense-8,672,827
Operating Income1,077,819-5,951,365
 
Operating Expense (+$)
Research Development148,863
Selling General Administrative1,147,298
Selling And Marketing Expenses-
Operating Expense8,672,8271,296,161
 
Net Interest Income (+$)
Interest Income1,178
Interest Expense-334,870
Other Finance Cost-8,450
Net Interest Income-325,241
 
Pretax Income (+$)
Operating Income1,077,819
Net Interest Income-325,241
Other Non-Operating Income Expenses-
Income Before Tax (EBT)741,7731,077,819
EBIT - interestExpense = -334,870
395,156
730,026
Interest Expense334,870
Earnings Before Interest and Taxes (EBIT)-1,076,643
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax741,773
Tax Provision-180,392
Net Income From Continuing Ops561,382561,382
Net Income395,156
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-325,241
 

Technical Analysis of Shanghai Runda Med Tech Co
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Shanghai Runda Med Tech Co. The general trend of Shanghai Runda Med Tech Co is BULLISH with 71.4% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Shanghai Runda Med Tech Co's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (71.4%) Bearish trend (-71.4%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Shanghai Runda Med Tech Co.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 25.39 < 25.79 < 27.70.

The bearish price targets are: 19.35 > 12.16 > 12.11.

Tweet this
Shanghai Runda Med Tech Co Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Shanghai Runda Med Tech Co. The current mas is .

The long score for the Moving Averages is 12/14.
The longshort score for the Moving Averages is 10/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Shanghai Runda Med Tech Co Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Shanghai Runda Med Tech Co. The current macd is 0.86508478.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Shanghai Runda Med Tech Co price going down in the near term. -2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Shanghai Runda Med Tech Co. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Shanghai Runda Med Tech Co price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Shanghai Runda Med Tech Co Daily Moving Average Convergence/Divergence (MACD) ChartShanghai Runda Med Tech Co Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Shanghai Runda Med Tech Co. The current adx is 39.69.

The long score for the Directional Movement Index (DMI) is 3/7.
The longshort score for the Directional Movement Index (DMI) is 3/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Shanghai Runda Med Tech Co shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bullish trend. The ADX is declining, the bullish trend is weakening. Could be a potential reversal to the downside. +2
Shanghai Runda Med Tech Co Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Shanghai Runda Med Tech Co. The current sar is 24.81.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Shanghai Runda Med Tech Co Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Shanghai Runda Med Tech Co. The current rsi is 50.63. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending up: The RSI is trending up. +1
Shanghai Runda Med Tech Co Daily Relative Strength Index (RSI) ChartShanghai Runda Med Tech Co Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Shanghai Runda Med Tech Co. The current phase is Oversold in bull market.

The long score for the Stochastic Oscillator is 1/6.
The longshort score for the Stochastic Oscillator is -4/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Shanghai Runda Med Tech Co price going down in the near term. -2
  • Trending up: The STOCH %K is trending up. +1
Shanghai Runda Med Tech Co Daily Stochastic Oscillator ChartShanghai Runda Med Tech Co Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Shanghai Runda Med Tech Co. The current cci is -32.67876869.

Shanghai Runda Med Tech Co Daily Commodity Channel Index (CCI) ChartShanghai Runda Med Tech Co Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Shanghai Runda Med Tech Co. The current cmo is -7.1359686.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Shanghai Runda Med Tech Co Daily Chande Momentum Oscillator (CMO) ChartShanghai Runda Med Tech Co Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Shanghai Runda Med Tech Co. The current willr is -80.47138047.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Shanghai Runda Med Tech Co Daily Williams %R ChartShanghai Runda Med Tech Co Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Shanghai Runda Med Tech Co.

Shanghai Runda Med Tech Co Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Shanghai Runda Med Tech Co. The current atr is 1.40517961.

Shanghai Runda Med Tech Co Daily Average True Range (ATR) ChartShanghai Runda Med Tech Co Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Shanghai Runda Med Tech Co. The current obv is 929,932,890.

Shanghai Runda Med Tech Co Daily On-Balance Volume (OBV) ChartShanghai Runda Med Tech Co Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Shanghai Runda Med Tech Co. The current mfi is 61.89.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Shanghai Runda Med Tech Co Daily Money Flow Index (MFI) ChartShanghai Runda Med Tech Co Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Shanghai Runda Med Tech Co.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-02STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-03WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-11-07RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-08STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-09BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-10STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-11-14STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-11-15STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-16RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2023-11-20STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-21MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-11-22STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-27CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-11-28WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-11-30STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-01CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-05STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-07SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-11STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-12STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-13STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-14SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-18CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-19DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-22STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-26STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-28MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-12-29MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-02WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-03STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-04STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-05STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-09MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-12SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-17STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-18MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-19MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-22BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-24WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-25MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-01-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-29MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-30BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-02-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-06RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-07SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-02-19MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-21STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-22STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-23DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-02-26CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-04BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-07SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-03-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-11CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-12SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-03-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-18BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-19MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-20STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-21RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-25SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-26MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-27WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside

6.3. Candlestick Patterns

Shanghai Runda Med Tech Co Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Shanghai Runda Med Tech Co based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5050.627
Ma 20Greater thanMa 5021.198
Ma 50Greater thanMa 10018.536
Ma 100Greater thanMa 20020.321
OpenGreater thanClose20.100
Total3/5 (60.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Shanghai Runda Med Tech Co with someone you think should read this too:
  • Are you bullish or bearish on Shanghai Runda Med Tech Co? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Shanghai Runda Med Tech Co? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Shanghai Runda Med Tech Co

I send you an email if I find something interesting about Shanghai Runda Med Tech Co.


Comments

How you think about this?

Leave a comment

Stay informed about Shanghai Runda Med Tech Co.

Receive notifications about Shanghai Runda Med Tech Co in your mailbox!